Medicrea Third Quarter 2018 Sales
Summary
LYON, France and NEW YORK--( BUSINESS WIRE )--The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTY & MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, publishes its sales for the 3 rd quarter ended September 30, 2018.This demonstrates the relevance of the solution we offer, which will gradually become the reference by replacing the traditional approach of spine surgery," commented Denys Sournac, President and CEO of Medicrea.In a market that commoditizes implants and prioritizes the optimization of clinical outcomes for the well-being of patients, our planning solutions set a new standard that we must rely on to offer all of our services and products in order to accelerate the development of our revenue "says Denys Sournac.Medicrea will be attending the 53rd Spine Research Society (SRS) Conference taking place in Bologna, Italy, from October 10 to 13, during which the company will present a new study demonstrating that patients implanted with UNiD ASI ™ patient-specific rods are 2.6 times more likely to be optimally corrected.Operating in a $10 billion marketplace, Medicrea is a Small and Medium sized Enterprise (SME) with 200 employees worldwide, which includes 50 who are based in the U.S.